Literature DB >> 22865034

Endometrial thickness measurement throughout a menstrual cycle in non-obese infertile patients with polycystic ovary syndrome.

Ozlem Gun Eryilmaz1, Esma Sarikaya, Cavidan Gulerman, Serra Akar, Nedim Cicek.   

Abstract

PURPOSE: To analyze the changes in the endometrial thickness in infertile polycystic ovary syndrome (PCOS) patients throughout an entire menstrual cycle and compare the changes to those seen in infertile patients without PCOS.
METHODS: This prospective, cross-sectional study was conducted in a total of 58 non-obese, infertile women with PCOS. The endometrial thickness was measured at three different times throughout the menstrual cycle by ultrasound. Age- and body mass index (BMI)-matched control group consisted of 62 non-obese infertile patients without PCOS. Demographic, hormonal and the ultrasonographic measurements of the two groups were compared.
RESULTS: Day 3 levels of LH were significantly different between the groups (p=0.013). Ovarian volume measurement was significant between the groups (p=0001). All the endometrial thickness measurements in the early, mid-cycle and late luteal phases were also significantly different; p=0.001 for all.
CONCLUSION: The study demonstrated an increased endometrial stripe measurements throughout a menstrual cycle in infertile patients with PCOS, when compared to infertile patients without PCOS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865034     DOI: 10.1007/s00404-012-2488-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS.

Authors:  Chen Cheng; Haolin Zhang; Yue Zhao; Rong Li; Jie Qiao
Journal:  J Assist Reprod Genet       Date:  2015-10-06       Impact factor: 3.412

2.  Decreased Endometrial Thickness Is Associated With Higher Risk of Neonatal Complications in Women With Polycystic Ovary Syndrome.

Authors:  Jialyu Huang; Jiaying Lin; Leizhen Xia; Lifeng Tian; Dingfei Xu; Peipei Liu; Jing Zhu; Qiongfang Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.